SOPHARMA AD - Notification - Veta Pharma AD

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 99 / 2016

Date of issue: 2016-11-04

Short name of the issuer

SOPHARMA AD

Subject

Notification - Veta Pharma AD

Official market - legal basis

art. 17. 1 MAR.

Unofficial market - legal basis

Contents of the report:

The Board of Directors of Sopharma AD decided to purchase up to 100% of the capital of “Veta Pharma” AD for a price not exceeding 2.12 BGN per share. The Board authorised the Executive Director to undertake all necessary legal actions thereby. “Veta Pharma” AD is a modern and dynamic Bulgarian pharmaceutical porducer of 47 different products divided in three categories: medicinal products, food additives and cosmetic products. The volume of sales for 2015 exceeds 3 million packages on the Bulgarian pharmaceutical market. 50 people work at the company. “Veta Pharma” AD plans, produces and distributes its products in accordance with the Good Manufacturing Practice (GMP) and the standards applied by the Bulgarian and European legal framewok.

Annexes

File Description

Uvedomlenie Veta pharma 04112016_2_en.doc Notification - Veta Pharma AD

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD Farmaceutyczny (far)

(short name of the issuer) (sector according to clasification of the WSE in Warsow)

1220 Sofia

(post code) (city)

IlienskoShosse 16

(street) (number)

[phone] [phone]

(phone number) (fax)

(e-mail) (web site)

nd

(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date Name Position / Function Signature

2016-11-04 Ognian Donev Executive director